Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 5/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.38 |
| ▸ | ERN1 | O75460 | 2/20 | 0.38 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.36 |
| ▸ | VRK1 | Q99986 | 1/20 | 0.36 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | PLAT | P00750 | 1/20 | 0.35 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | F7 | P08709 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28443593 | 0.81 | ALDH1A1 (0.41) | ARHSD17B1HSD17B2KDM4EMEN1 | |
| SCHEMBL17840122 | 0.80 | FEN1 (0.42) | ARAKR1C3RPS6KA3MAOB | |
| SCHEMBL2530485 | 0.80 | HSD17B1 (0.49) | AKR1C3RPS6KA3HSD17B1HSD17B2AKR1C2 | |
| SCHEMBL31589709 | 0.80 | ALDH1A1 (0.54) | ARAKR1C3RPS6KA3HSD17B1HSD17B2 | |
| SCHEMBL2132813 | 0.78 | FEN1 (0.41) | ARAKR1C3RPS6KA3 | |
| SCHEMBL2132817 | 0.77 | RPS6KA3 (0.40) | AKR1C3RPS6KA3AKR1C2AKR1C1MEN1 | |
| SCHEMBL13439489 | 0.76 | PTPRC (0.48) | ERN1KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL30665737 | 0.76 | PTPRC (0.48) | ERN1KDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL1252515 | 0.74 | ERN1 (0.36) | ARAKR1C3RPS6KA3ERN1 | |
| SCHEMBL16355406 | 0.73 | MAOA (0.36) | ERN1HSD17B14KDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102329332-B | Organo-aluminum compound | TAKAMASAGO PERFUME INDUSTRIAL CO., LTD. (JP) | 2016-05-04 | — | — | CN | disclosed |
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| EP-2921228-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | Takasago International Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
| US-9061959-B2 | Method for manufacturing optically active menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| EP-2647616-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | Takasago International Corporation (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-26 | — | — | US | disclosed |
| US-8329931-B2 | Organoaluminum compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20110295031-A1 | ORGANOALUMINUM COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-12-01 | — | — | US | disclosed |
| EP-2390001-A1 | Organoaluminium compounds and their use as catalysts in the selective cyclisation of citronellal to isopulegol | Takasago International Corporation (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110256013-A1 | METHOD FOR PRODUCING REGENERATED TARGET | TANAKA HOLDINGS CO., LTD. (JP) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329452-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL | ACSL3, ACSL6, ALOX5 | AR 57/4885AKR1C3 267/4885RPS6KA3 2926/4885 |
| US-20110295031-A1 | ORGANOALUMINUM COMPOUND | CDC5L, ACSL3, MSMO1 | AR 1009/4885AKR1C3 87/4885RPS6KA3 4622/4885 |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | MSMO1, GGPS1, MAN1B1 | AR 3987/4885AKR1C3 286/4885RPS6KA3 2287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.